Lupin Limited has informed the Exchange regarding a revised press release dated December 15, 2023, titled "Lupin Receives Approval from U.S. FDA for Allopurinol Tablets.".
Lupin Limited has informed the Exchange regarding a revised press release dated December 15, 2023, titled "Lupin Receives Approval from U.S. FDA for Allopurinol Tablets.".